Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dapagliflozin (farxiga) (1 trial)
insulin aspart (novolog) (1 trial)
interferon alpha-2b (Intron-A) (3 trials)
metformin (glucophage) (1 trial)
saxagliptin (onglyza) (1 trial)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis, Chronic (Phase 4)
Trials (4 total)
Trial APIs (5 total)